Latest

News

MHC LLP Advises Surmodics on Acquisition of Vetex Medical

08 July 2021

We are pleased to have acted for Surmodics Inc. on the acquisition of Vetex Medical Limited.

Surmodics, a Nasdaq listed medtech company based in Minnesota, is a leading provider of medical device and in vitro diagnostic technologies to the health care industry.

The deal for Galway-based Vetex expands Surmodics’ thrombectomy portfolio with a second US FDA approved device, the ReVene Thrombectomy Catheter. This device developed by Vetex is specifically designed to remove large, mixed-morphology blood clots commonly found with venous thromboembolism.

Discuss your related queries now with Martin Kelleher.


Martin_Kelleher_(Web_153x230).jpg
  • LinkedIn